Multivitamins Show No Link To 'Lower Risk of Death,' Study Finds
Multivitamins Show No Link To 'Lower Risk of Death,' Study Finds
Taking a multivitamin once a day has long been considered a path to better health, but a new study refutes that widely held belief.
長期以來，每天服用一次綜合維生素被認爲是通往更健康的道路，但一項新研究駁斥了這一普遍信仰。
A study published in JAMA Network Open on Wednesday revealed that after tracking nearly 400,000 healthy adults for over 20 years, researchers found no link between regular multivitamin use and a lower risk of death, according to the National Institutes of Health.
根據國家衛生研究院的一項研究，週三在JAMA Network Open上發表的一項研究發現，在跟蹤近40萬名健康成年人20多年後，研究人員發現，定期服用綜合維生素與較低死亡風險之間沒有關聯。
The study was led by researchers at the National Institutes of Health's National Cancer Institute.
該研究由國家衛生研究院的國家癌症研究所的研究人員領導。
Also Read: Healthcare Advocates United: A Push For Congress To Recognize CBD As Dietary Supplements
還閱讀過：醫療保健倡導者團結一致：推動國會承認CBD爲膳食補品
"The analysis showed that people who took daily multivitamins did not have a lower risk of death from any cause than people who took no multivitamins," Erikka Loftfield, Ph.D., M.P.H., a researcher with the division of cancer epidemiology and genetics at the National Cancer Institute, wrote in the study.
“分析顯示，每天服用綜合維生素的人死於任何原因的風險不比不服用綜合維生素的人低，”國家癌症研究所癌症流行病學和遺傳學分部的研究員Erikka Loftfield博士、公共衛生碩士在研究中寫道。
"There were also no differences in mortality from cancer, heart disease, or cerebrovascular diseases. The results were adjusted for factors such as race and ethnicity, education, and diet quality."
“在癌症、心臟病或腦血管疾病的死亡率方面也沒有差異。該結果已調整爲因素，如種族和民族、教育和飲食質量。”
Loftfield also emphasized the importance of assessing the risk of death associated with multivitamin use in different populations, such as those with documented nutritional deficiencies. She highlighted the need to explore the potential impact of regular multivitamin use on aging-related health conditions.
Loftfield還強調了在不同人群中評估與綜合維生素使用相關的死亡風險的重要性，例如那些存在營養缺乏的人群。她強調了探索定期服用綜合維生素對與年齡相關的健康狀況的潛在影響的必要性。
Price Action: Despite the study's findings on multivitamin use, related health and wellness companies saw varied market reactions. By Thursday's afternoon trading, BellRing Brands, Inc. (NYSE:BRBR) gained 1.08% to $57.89, Herbalife Ltd. (NYSE:HLF) slipped 1.03% to $10.52, and USANA Health Sciences, Inc. (NYSE:USNA) was up 1% to $45.44.
價格走勢：儘管該研究發現綜合維生素的使用情況，相關的健康和福祉公司看到了不同的市場反應。截至週四下午交易，BellRing Brands, Inc. (紐交所:BRBR) 上漲1.08%，至57.89美元，康寶萊有限公司 (紐交所:HLF) 下跌1.03%，至10.52美元，賽百味健康科學公司 (紐交所:USNA) 上漲1%，至45.44美元。
Invesco S&P SmallCap Consumer Staples ETF (NASDAQ:PSCC) slipped 0.09% by early afternoon, while VegTech Plant-based Innovation & Climate ETF (NYSE:EATV) remained unchanged and Invesco Food & Beverage ETF (NYSE:PBJ) declined 0.68%.
早盤，英壽標普小型消費者穩定收益ETF (納斯達克:PSCC) 下跌0.09%，而VegTech植物爲基礎的創新與氣候ETF (紐交所:EATV) 保持不變，英壽食品與飲料ETF (紐交所:PBJ) 下跌0.68%。
- Gianni Di Poce Rings The Bell On BellRing Brands, Calls For 42% Returns
- Gianni Di Poce爲BellRing Brands敲響鐘聲，呼籲獲得42%的回報。
Photo: Shutterstock
Photo: shutterstock